GlassScriptPhysician profile
Harris H Mones
NPI 1497718571
$695.92
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $233 · 2021: $70.91 · 2022: $76.56 · 2023: $52.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $145.01 | 2019-2020 | |
| Viiv Healthcare Company | $98.87 | 2019-2023 | Apretude |
| Allergan, INC. | $73.22 | 2020 | |
| Abbvie INC. | $65.58 | 2021-2023 | |
| Glaxosmithkline, LLC. | $40.73 | 2020 | |
| Pfizer INC. | $39.24 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $36.01 | 2019-2021 | |
| Amarin Pharma, INC. | $34.59 | 2019-2020 | |
| Ethicon US, LLC | $29.71 | 2019 | |
| Redhill Biopharma INC. | $24.08 | 2020 | |
| Forte Bio-Pharma LLC | $18.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.47 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $16.38 | 2022 | |
| Novo Nordisk INC | $15.78 | 2020 | |
| Genentech USA, INC. | $14.63 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.09 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harris Mones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.